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Aflatrem: A Tremorgenic Mycotoxin with
Acute Neurotoxic Effects
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Richard J. Colet
Tremorgenic mycotoxins induce neurologic symptoms ranging from mental confusion to tremors, sei-
zures and death, and are apparently the only class of mycotoxins with significant central nervous system
activity. Tremorgens have been implicated in a number of neurologic diseases ofcattle collectively known
as staggers syndromes, and pose significant agricultural and health problems for both cattle and humans.
Although the effects of tremorgens are thought to result from transient perturbations of amino acid
neurotransmitter release mechanisms, there is reason to believe that acute exposures to toxins with such
synaptic effects may result in degeneration of neuronal fiber processes. To test this hypothesis, rats were
given a single tremorgenic (3 mg/kg, IP) dose of aflatrem, and kinetics of amino acid neurotransmitter
uptake was assessed in isolated hippocampal nerve terminals at 1 day, 1 week, and 2 weeks after injection.
Results indicate a decrease in the capacity of the GABA and glutamate uptake systems, which was
interpreted as a loss of nerve terminals. The affinity constants suggest a decrease in release of these
transmitters as well. In addition to its transient influence on transmitter release, a single low dose of
aflatrem is able to induce degeneration of neuronal processes in hippocampal neurotransmitter systems
and therefore represents a long-term health threat.
Introduction
A group of fungal metabolites collectively known as
tremorgenic mycotoxins have been identified as the
causative agents of a neurological disease ofcattle known
as "staggers syndrome"(1). This diseaseis characterized
by muscle tremors and hyperexcitability, and similar
responses have been observed in laboratory animals
treated with the mycotoxins (2,3). The fungi which pro-
duce these compounds have been isolated from corn,
silage, and various forages (2), and so pose a health
threatforbothlivestockand humanswho consume these
commodities.
The mechanism of action of these tremorgens is un-
known, but indirect evidence suggests a neurochemical
(4), rather than a cytotoxic, basis for the symptoms.
Two lines of evidence seem to support this conclusion.
First, tremorgenic mycotoxins do not appearto produce
any gross histopathological lesions (5,6). Second, glu-
tamate and -y-aminobutyric acid (GABA), which are,
respectively, generally excitatory and inhibitory amino
acid neurotransmitter candidates, have been reported
to respond to exposure to tremorgens. Rats treated
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with tremorgenic doses of verruculogen, the most po-
tent compound in this group, evince increased gluta-
mate, and decreased GABA, levels in brain tissue (4,7,8).
These effects apparently occur in subcortical tissue and
are completely reversible (4), leading to the inference
that the tremorgens perturb biochemical processes in-
volved with neurotransmitter release. This conclusion,
however, is based on indirect evidence.
Excitotoxic (9) compounds are known to induce cell
death possibly as a result of sustained depolarization,
and some neurotoxins with presynaptic activity such as
black widow spider venom (10) and Bungarus snake
venoms (11) produce nerve terminal degeneration.
Analogously, it follows that the biochemical alteration
triggered bytremorgenic mycotoxins could induce mor-
phological changes in the nerve terminal which would
be manifest some time after the exposure, and would
not appear as gross lesions.
Neurotransmitter uptake is a specific and sensitive
marker for the presence or absence of nerve terminals
utilizing a particular neurotransmitter (12). Kinetic an-
alysis of such data yields an estimate of alterations in
the number (VmQ) or affinity (Km) of these terminals,
from which inferences about nerve terminal degenera-
tion can be made. Both glutamate and GABA are im-
portant neurotransmitters in the hippocampus, and the
low seizure threshold of this structure (13) makes it aVALDES, CAMERON, AND COLE
likely target for tremorgenic mycotoxins. Accordingly,
the effects of the classic tremorgen aflatrem (14) on
amino acid neurotransmitter uptake were assessed in
rat hippocampal synaptosomes isolated at various times
after injection of one tremorgenic dose.
Materials and Methods
Subjects
Male albino [AMRI(SD x WI) BR; N= 12] rats
weighing 220-330 g were housed singly in metal cages
and allowed ad libitum access to laboratory chow (Pur-
ina) and tap water. They were housed under conditions
ofcontrolled temperature (24 + 2°C) and humidity (30-
70%) on a 12 hr light/dark schedule and allowed to ac-




and glutamic acid (3H-Glu: 44.1 Ci/mM) were obtained
from New Enmland Nuclear. The following stock con-
centrations of H-GABA(0.33Ci/mM)and3H-glutamate
(1.1 Ci/mM) were used in the experiment: 1.0 x 10-5
M, 7.5 x 10-6 M, 5.0 x 10-6 M, 2.5 x 10-6 M, 1.0 x
10-6 M, 7.5 x 10-7 M. Final incubation concentrations
represented a 100 x dilution.
Toxins
Purified aflatrem crystals were dissolved in dimethyl
sulfoxide (DMSO) to a final concentration of 3 mg/cm3.
Toxin was prepared by fermentation from Aspergillus
flavus and purified to greater than 98% using its UV
extinction coefficient.
Reagents and Buffers
Modified Krebs-Henseleit buffer was made up of 1.2
mM MgSO4, 1.5 mM CaCl, 10 mM glucose, 2.5 mM
HEPES, 145 mM NaCl, 5 mM KCI, 10 ,uM aminooxy-
acetic acid (pH 7.4).
HEPES-Sucrose homogenization medium consisted
of 0.32 M sucrose and 2.5 mM HEPES (pH 7.4).
Procedures
Preliminary Experiments. The effects of 20OuL
DMSO on uptake was assessed in a pilot study. Exper-
imental procedures were as described in Uptake Sec-
tion. Since DMSO at this concentration did not alter
transport, it was used in subsequent studies due to its
superior ability to dissolve the mycotoxins.
Uptake: In Vivo Toxin Exposure. Rats (N = 12)
were given intraperitoneal injections of either DMSO
or a tremorgenic dose of aflatrem (3 mg/kg IP), and
decapitated at 24 hr, 1 week, and 2 weeks after the
injection. Day of injection was staggered so that any
given experiment contained tissue from rats killed at
eachtimepointpost-injection. Thebrainswereremoved
to an ice cold dissecting plate; hippocampus (HIP) was
rapidly dissected, weighed, and homogenized in 20 vol-
umes sucrose-HEPES medium with aTeflon pestle and
matched smooth glass homogenizer (Wheaton, 10 strokes
on ice, setting 3). The volumes were adjusted to 20 mL,
and the homogenates were centrifuged at lOOOg (JA-20
rotor) for 10 min at 6°C.
Thepelletswere discarded andthe supernatantswere
centrifuged at 17000g (JA-20 rotor) for 20 min at 6°C.
Pellets were resuspended in 5mL modified Krebs-Hen-
seleit buffer by hand homogenization (5 strokes). The
following were combined in duplicate test tubes: 1880
FL Krebs-Henseleit; 20 ,L either 3H-GABA (six con-
centrations prepared as in Radioisotope section) or 3H-
glutamate (six concentrations prepared as in Radiois-
otope section); 100 ,LL HIPtissue suspension. Thetubes
were incubated at either 38°C or 0°C for 10 min, uptake
being linear in this preparation over this time period,
andthecontentswereaspirated ontofilterstrips (What-
man GF-B) with a Brandel tissue harvester and washed
three times with cold physiological saline (0.9%). The
filter disks were placed in Hang-in vials (Packard) to
which 5 mL Formula 947 (New England Nuclear) was
added, and counted in aPackard 300-c scintillation spec-
trometer (63% efficiency).
Data Treatment
The data were expressed as moles oftransmitter per
microgram of synaptosomal protein per minute (mole/
pzg P/min) of incubation. The 0°C incubation was used
as control for nonspecific uptake and subtracted from
that obtained at 38°C to yield temperature-sensitive up-
take. The data for each neurotransmitter were com-
bined acrossexperiments and graphed as a Lineweaver-
Burk plot (15) for visual representation only, with ki-
netic constants Km and Vmax, representing the affinity
and capacity, respectively, of the uptake system, de-
termined by computer using a program based on a
weighted least-squares analysis derived from the Wilk-
inson equations (16). Each data point in each of the
Lineweaver-Burk plots shown in Figures 3 and 4 below
represents the mean ofthe uptake values ofthree rats
at that transmitter concentration. The kinetic constants
reported in Results were computed using these values.
Additionally, kinetic constants Km and Vmax were com-
puted from the data from each rat at each time point
forbothtransmitters. These valueswerethensubjected
tostatistical analysesusingone-wayanalysis ofvariance
and Newman-Keuls test for subsequent comparisons
among time points.
Results
Uptake of both 3H-GABA (Fig. 1) and 3H-glutamate
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FIGURE 1. 3H-GABA uptake velocity (mole/,ug P/min) as a function
of transmitter concentration.
concentrations and for all time points assessed. Kinetic
analyses indicated a similar pattern of alterations for
both neurotransmitters. The data for3H-GABA uptake
are presented as a double reciprocal plot in Figure 3.
At 24 hr post-injection, 3H-GABA uptake was charac-
terized by a 106% increase in Km (Km = 20.2 x 10-7M)
and a 125% increase in Vmax (25.3 x 10-13 mole/,ug P/
min) relative to control values (Km = 9.8 x 10-7 M, Vma,
= 11.2 x 10-13 mole/,ug P/min). At one week post-in-
jection, Km (Km = 4.8 x 10-7M) and Vmax (Vmax = 5.6
x 10-3mole/,ugP/min)weredecreasedby51%and50%,
respectively, compared to control values. This trend
was stable at two weeks post-injection, with Km (Km =
4.8 x 10-7M) and Vmax (Vmax = 4.4 x 10-13 mole/,ug P/
min) beingreduced 51% and 60%, respectively, relative
to control values. Statistical analysis ofthese datausing
one-wayANOVAindicatesasignificantalterationof3H-
GABA Km over time after aflatrem injection (F = 72,
df = 3,8, p<0.001). Subsequent comparisons using the
Newman-Keuls test showed a statistically significant
increase of Km at 24 hr (p<0.01), and decreased Km at








FIGURE 2. 3H-Glutamate uptake velocity (mole/,ug P/min) as a func-
tion of transmitter concentration.
control. WhentheVmax datawere subjected toANOVA,
a similar pattern of significant alterations occurred (F
= 91, df = 3, 8, p<0.001). Vmax increased significantly
at 24 hr (p<0.01) relative to control. The data for 3H-
glutamate uptake are presented as a double reciprocal
plot in Figure 4. At 24 hr post-injection, 3H-glutamate
uptake was characterized by a 113% increase in Km (Km
= 4.7 x 10-7M) and a 150% increase in Vmax (Vmax =
5.0 x 10-13 mole/,ug P/min) relative to control values
(Km = 2.2 x 10-7M; Vmax = 2.0 x 10-l3mole/4gP/min).
These values returned to approximate control levels by
1 week post-injection (Km = 2.6 x 10-7M; Vmax = 2.5
x 10-13 mole/tgP/min), and then decreased by 77% (Km
= 0.5 x 10- M) and 45% Vmax = 1.1 x 10-'3 mole/pg
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FIGURE 3. Lineweaver-Burk plot of'H-GABA uptake.462 VALDES, CAMERON, AND COLE
usingone-wayANOVAindicates asignificant alteration
of 3H-glutamate Km over time after aflatrem injection
(F = 155, df = 3, 8, p<0.001). Subsequent comparisons
usingthe Newman-Keuls test showed astatistically sig-
nificant increase ofKm at 24 hr (p<0.01), a smaller, but
statistically significant increase at 1 week (p<0.05), and
a statistically significant decrease at 2 weeks (p<0.01).
Analysis oftheVma, dataviaone-wayANOVArevealed
significant alterations ofthis kinetic constant over time
afterinjection (F = 45, df = 3, 8,p<0.001). Subsequent
comparisons indicated an increase of Vmax at 24 hr
(p<0.01) and a gradual decrease over time, reaching
values significantly lower than control at two weeks
(p<0.01). In summary, both neurotransmitter uptake
systems initially respond to the aflatrem exposure with
decreased affinity and increased capacity, and then re-
verse this trend within two weeks.
Discussion
Neurotransmitter uptake is a dynamic process which
is primarily responsible for inactivating released trans-
mitter and providing material for the depleted stores.
The rate and amount of uptake are regulated by de-
mand; increased release or decreased synthesis induces
increased uptake. Therefore, an interpretation of the
biphasic nature of these uptake data must account for
the potential acute effects of aflatrem on transmitter
release. Specifically, if aflatrem modulates transmitter
release as has been hypothesized for verruculogen
(4,7,8), uptake measurements made during this acute
phase of toxicity would be confounded by the compen-
satory response of the uptake system to the altered
demand.
Kinetic analyses of the data at 24 hr post-injection
indicates large increases in uptake capacity (Vmax) and
decreases in affinity (i.e., increased Km) for both trans-
mitter uptake systems. Two interpretations are im-
mediately apparent. First, if aflatrem has, as an acute
effect, the enhanced release of transmitters from the
nerve terminals, the uptake systems would be required
to step up activity in order to replenish transmitter
stores to meet demand. Second, the heightened levels
of endogenous transmitters in the synaptic cleft which
areconsequencesofincreasedrelease creates asituation
in which the endogenous and exogenous (i.e., tritiated)
transmitters compete for the available uptake sites.
These two interpretations are complementary, the first
accounting forthe increased Vmax and the second for the
increased K-.
This sequence of events would probably be confined
to the initial acute stages oftoxicity and would not be
involved as an explanation for later changes. By two
weeks post-injection, both systems show decreased ca-
pacity and increased affinity for their respective trans-
mitters. Since high affinity uptake is a reliable marker
forthe presence ofnerve terminals utilizing aparticular
transmitter (12), the decreased Vmax values indicate
either a loss ofboth GABAergic and glutaminergic nerve
terminals, or an impairment of the storage mechanism
(e.g., failure to repackage vehicles in these treated an-
imals). A definitive resolution of this issue awaits his-
topathological studies using stains specific for neuronal
degeneration.
The increased affinity at the two week point is com-
patible with an explanation based on perturbation of
release mechanisms. Specifically, decreased release from
the intoxicated nerve terminals would result in lower
levels of transmitter in the synaptic cleft, hence less
competition for the available uptake sites. The result
would be an apparent increase in affinity. Alternately,
and less likely, the toxin may differentially damage some
subset of nerve terminals with particular (i.e., lower
affinity) uptake characteristics, thus favoring the sur-
vival of a population of nerve terminals with higher
affinities for the transmitters.
It is apparent that an explanation ofafiatrem toxicity
must address the possibility that a single tremorgenic
dose induces neuronal pathology which is expressed over
a period of weeks. This pathology is most likely nerve
terminal degeneration as indicated by the decreased
synaptic uptake ofamino acid neurotransmitters. Other
possibilities, such as interference with transmitter syn-
thesis or storage, cannot be definitively ruled out, how-
ever. Several questions remain: it is an open question
as to how the hypothesized degeneration is induced,
whether it is specific to amino acid transmitter systems
orthe result ofsome general metabolic mechanism com-
mon to all types of neurons, and whether this neuro-
toxicity is acharacteristic ofalltremorgenic mycotoxins.
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